Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.50 |
| ▸ | MAPT | P10636 | 7/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 4/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HRH2 | P25021 | 1/20 | 0.32 |
| ▸ | HRH1 | P35367 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13367285 | 0.87 | ALDH1A1 (0.39) | ALDH1A1MAPTKMT2ASMN1; SMN2CYP1A2 | |
| SCHEMBL16644651 | 0.87 | MAPT (0.46) | ALDH1A1MAPTKMT2ASMN1; SMN2CYP1A2 | |
| SCHEMBL12697310 | 0.86 | MAPT (0.58) | ALDH1A1MAPTKMT2ASMN1; SMN2CYP1A2 | |
| SCHEMBL17980841 | 0.84 | MAPT (0.56) | ALDH1A1MAPTKMT2ASMN1; SMN2CYP1A2 | |
| SCHEMBL19057319 | 0.84 | MAPT (0.53) | ALDH1A1MAPTKMT2ASMN1; SMN2CYP1A2 | |
| SCHEMBL8334981 | 0.83 | KMT2A (0.47) | ALDH1A1MAPTKMT2ASMN1; SMN2CYP1A2 | |
| SCHEMBL17175280 | 0.81 | MAPT (0.52) | ALDH1A1MAPTKMT2ASMN1; SMN2CYP1A2 | |
| SCHEMBL13952961 | 0.79 | MAPT (0.58) | ALDH1A1MAPTKMT2ASMN1; SMN2CYP1A2 | |
| SCHEMBL15613436 | 0.79 | MAPT (0.50) | ALDH1A1MAPTKMT2ASMN1; SMN2CYP1A2 | |
| SCHEMBL16790911 | 0.78 | KMT2A (0.49) | ALDH1A1MAPTKMT2ASMN1; SMN2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170340759-A1 | RADIO-PHARMACEUTICAL COMPLEXES | BAYER AS (NO) | 2017-11-30 | — | — | US | disclosed |
| US-20170319721-A1 | ALPHA-EMITTING COMPLEXES | BAYER AS (NO) | 2017-11-09 | — | — | US | disclosed |
| WO-2017162555-A1 | RADIO-PHARMACEUTICAL COMPLEXES | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2017-09-28 | — | — | WO | disclosed |
| US-9724436-B2 | Alpha-emitting complexes | BAYER AS (NO) | 2017-08-08 | — | — | US | disclosed |
| US-9439984-B2 | Macrocycles | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-09-13 | — | — | US | disclosed |
| US-20150157746-A1 | MACROCYCLES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2015-06-11 | — | — | US | disclosed |
| WO-2013187971-A2 | MACROCYCLES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-12-19 | — | — | WO | disclosed |
| US-20130183235-A1 | ALPHA-EMITTING COMPLEXES | ALGETA ASA (NO) | 2013-07-18 | — | — | US | disclosed |
| US-7718781-B2 | Hydroxypyridonate and hydroxypyrimidinone chelating agents | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-05-18 | — | — | US | disclosed |
| WO-2007121453-A2 | 2-HYDROXY-1-OXO 1,2 DIHYDRO ISOQUINOLINE CHELATING AGENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-10-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130183235-A1 | ALPHA-EMITTING COMPLEXES | TK1, KPNA1, HPRT1 | ALDH1A1 1665/4885MAPT 2019/4885KMT2A 2716/4885 |
| US-20170319721-A1 | ALPHA-EMITTING COMPLEXES | TK1, KPNA1, HPRT1 | ALDH1A1 1665/4885MAPT 2019/4885KMT2A 2716/4885 |
| US-20150157746-A1 | MACROCYCLES | SLC39A14, SLC39A3, SLC40A1 | ALDH1A1 3621/4885MAPT 4228/4885KMT2A 2927/4885 |
| US-20170340759-A1 | RADIO-PHARMACEUTICAL COMPLEXES | PTMS, THOP1, PHPT1 | ALDH1A1 3524/4885MAPT 917/4885KMT2A 4075/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.